Takeda To Rely On M&A, Emerging Market Expansion To Offset Patent Losses

Japan's largest drug company Takeda hopes to minimize the impact of looming patent expirations in the U.S. by relying on mergers and acquisitions to increase its pipeline and extend its territory coverage, especially in emerging countries